-
National Procurement Enlarged Moves! 257 drugs are at risk of "substitution"
Time of Update: 2022-10-21
A few days ago, the National Health Insurance Administration updated the reference monitoring scope list of the first seven batches of nationally sourced alternative drugs, aiming to strengthen the monitoring of clinical dosage and price changes of alternative drugs, and ensure the priority use of selected drugs in centralized procurement and the fairness of the online market.
-
Pharmaceutical retail, 5 ways to survive the "labor pain" of transformation
Time of Update: 2022-10-20
Having witnessed the glory of the "golden decade" of the pharmaceutical retail industry, and accustomed to seeing the upward performance growth curve of listed chains, I was shocked to see a sharp decline in the half-year net profit of listed chains, including Yixintang, which is known for its steady operation.
-
Strong market demand and growth space in the segment of ophthalmic consumables has opened
Time of Update: 2022-10-20
, Ltd. announced the completion of a series B financing of 420 million yuan, mainly for the research and development and expansion of decorative color contact lenses; in November of the same year, Weimu (Shanghai) Technology Co.
-
Why is building a healthy China a "lifestyle revolution"?
Time of Update: 2022-10-20
Why is building a healthy China a "lifestyle revolution"? ——Interview with Mao Qunan, Deputy Director of the Office of the Healthy China Action Promotion Committee and Director of the Department of P
-
China's original "non-invasive" surgical equipment was exported to Colombia for clinical treatment and research in the country
Time of Update: 2022-10-20
(End) On the 11th, a set of "non-invasive" surgical equipment originally created by China - "Haifu Knife" focused ultrasound tumor treatment system was sent from Chongqing to Colombia.
